Dr. Surya Teja Chennupati , DO
Internal Medicine β’ Lansing, MI
1322 E Michigan Ave Ste 202b
Lansing, MI 489122109
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Surya Chennupati is listed in NPPES under Internal Medicine.
-
NPI assigned on May 28, 2021; this date does not establish years in practice.
-
Published CMS data list 122 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Atorvastatin Calcium β 28 prescription fills, including refills.
- Albuterol Sulfate Hfa (Albuterol Sulfate) β 28 prescription fills, including refills.
- Gabapentin β 24 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 6 records in the table Β· Guide: How to read Medicare Part D prescriber data
-
Fewer Part D prescriptions than 60% of clinicians listed under Internal Medicine in Lansing, MI (2024, 94 clinicians with data). Median for this group: 148. Middle half: 83 to 2,213.
Fewer Part D prescriptions than 70% of clinicians listed under Internal Medicine in Michigan (2024, 3,463 clinicians with data). Median for this group: 801. Middle half: 94 to 5,032.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 84 in 2022 to 122 in 2024.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2022β2024.
Practice Location & Contact Primary Location
1322 E Michigan Ave Ste 202b
Lansing, MI 489122109
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Internal Medicine: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
205 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$13,735 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,448.41 across 66 records.
By nature of payment
- Food and Beverage: $1,368.47 across 65 records.
- Education: $79.94 across 1 record.
Reporting-company totals (3 largest of 14)
- AstraZeneca Pharmaceuticals LP: $340.05 across 14 records.
- Regeneron Pharmaceuticals, Inc.: $326.70 across 18 records.
- GlaxoSmithKline, LLC.: $181.66 across 4 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2021
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, βDoes your provider accept Medicare as full payment?β
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Can order Medicare-covered services
CMS lists Dr. Chennupati as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Lansing and Michigan
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Fewer Part D prescriptions than 60% of clinicians listed under Internal Medicine in Lansing, MI (2024, 94 clinicians with data). Median for this group: 148. Middle half: 83 to 2,213.
Fewer Part D prescriptions than 70% of clinicians listed under Internal Medicine in Michigan (2024, 3,463 clinicians with data). Median for this group: 801. Middle half: 94 to 5,032.
Part D drug cost
Close to the middle for clinicians listed under Internal Medicine in Lansing, MI (2024, 94 clinicians with data). Median for this group: $13,988. Middle half: $1,477 to $261,021.
A lower Part D drug cost than 60% of clinicians listed under Internal Medicine in Michigan (2024, 3,463 clinicians with data). Median for this group: $66,958. Middle half: $1,946 to $462,816.
135 active clinicians are listed under Internal Medicine with a practice address in Lansing, MI (5,741 in Michigan).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Lansing
9.6% of these 135 clinicians have the CMS telehealth indicator.
51.1% of these 135 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 45% from 84 in 2022 to 122 in 2024.
- 2022: 84
- 2023: 149
- 2024: 122
-
30-day fills
30-day fills increased 95% from 105 in 2022 to 205 in 2024.
- 2022: 105
- 2023: 187
- 2024: 205
-
Part D drug cost
Part D drug cost increased 1190% from $1,065 in 2022 to $13,735 in 2024.
- 2022: $1,065
- 2023: $2,257
- 2024: $13,735
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $16.78 in 2021 to $1,448.41 in 2025.
- 2021: $16.78
- 2022: $60.17
- 2023: $236.04
- 2024: $554.59
- 2025: $1,448.41
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo Β· Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 β December 31, 2025): 66 records totaling $1,448.41.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
NUCALA | General | $119.48 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
TEZSPIRE | General | $110.96 |
| Regeneron Pharmaceuticals, Inc. |
Education
In-kind items and services
|
DUPIXENT | General | $79.94 |
| United Therapeutics Corporation |
Food and Beverage
In-kind items and services
|
Tyvaso | General | $31.98 |
| HARMONY BIOSCIENCES LLC |
Food and Beverage
In-kind items and services
|
WAKIX | General | $31.60 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
OPSYNVI | General | $29.65 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FASENRA | General | $29.40 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $28.29 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $27.18 |
| Avadel CNS Pharmaceuticals, LLC |
Food and Beverage
In-kind items and services
|
LUMRYZ | General | $26.69 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $25.54 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $25.16 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $24.25 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $23.94 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $23.86 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Xolair | General | $23.55 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $23.40 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
OPSUMIT | General | $23.28 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $22.89 |
| Viatris Specialty LLC |
Food and Beverage
In-kind items and services
|
YUPELRI | General | $22.84 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $22.74 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
OFEV | General | $22.53 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
NUCALA | General | $22.09 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
TEZSPIRE | General | $21.97 |
| Viatris Specialty LLC |
Food and Beverage
In-kind items and services
|
YUPELRI | General | $21.13 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 28 | 1,440 | $137.09 | β |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 28 | 869 | $1,050.91 | 14 |
| Gabapentin | Gabapentin | 24 | 1,089 | $404.67 | 12 |
| Lisinopril | Lisinopril | 15 | 900 | $89.20 | β |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 14 | 600 | $11,924.54 | β |
| Losartan Potassium | Losartan Potassium | 13 | 1,050 | $128.15 | β |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2026-07-06NUCC Taxonomy Code: 207R00000X
A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.
NUCC Taxonomy Code: 390200000X
An individual who is enrolled in an organized health care education/training program leading to a degree, certification, registration, and/or licensure to provide health care.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSSources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Internal Medicine
Doctor of Medicine (M.D.)
Student in an Organized Health Care Education/Training Program
Internal Medicine - Cardiovascular Disease
Bachelor of Medicine, Bachelor of Surgery (M.B.B.S.)
Student in an Organized Health Care Education/Training Program
Doctor of Medicine (M.D.)
Internal Medicine
Doctor of Medicine (M.D.), Master of Science
Internal Medicine
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Internal Medicine (license number reported to NPPES: MI 5101029583)
Student in an Organized Health Care Education/Training Program (license number reported to NPPES: MI 5151014911)
NPI status registered as active in NPPES database
Registered at 1322 E MICHIGAN AVE STE 202B, LANSING, MI 489122109 (Tel: 5172536388)
Registered at 1322 E MICHIGAN AVE STE 202B, LANSING, MI 489122109
Recorded as SURYA CHENNUPATI, DO
Internal Medicine (license number reported to NPPES: MI 5151014911)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Internal Medicine Providers in Lansing
- Dr. Tolam Nguyen, DO
- Dr. Ovidiu Batca, MD
- Dr. Mandar Ajgaonkar, MD
- Dr. Jill Barry, MD
- Dr. Erik Hemingway, MD
- Dr. Daniel Maccourtney, MD
Mailing Address
1322 E Michigan Ave Ste 202b
Lansing, MI 489122109